VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Timing is everything!

<< Previous

Bullboard Posts

Next >>

Comment by Retiremesouthon Nov 12, 2020 11:26am

135 Views

Post# 31885154

RE:RE:Timing is everything!

One of the points I agree with is the lack of specific wording from George in relation to news releases. And that word is "SOLD"

Any hospital placement (s) of the VMS+3.0 has been referred to as "Ventripoint is pleased to anounce that we have Installed the VMS+3.0 in whatever hospital"

Installed and Sold have two very different meanings.
Can anyone on this board actually back up the claim that they have sold any VMS+3.0 machines?

No bashing here, just a question.
Looking for clarity.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure